SAVA

2.35

2.62% 0.06

Handel nachbörslich: 2.35

Cassava Sciences Inc (SAVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SAVA? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$2.29

Offen:

$2.24

24-Stunden-Volumen:

3.17M

Relative Volume:

0.64

Marktkapitalisierung:

$113.06M

Einnahmen:

Nettoeinkommen (Verlust:

$-97.22M

KGV:

-1.0731

EPS:

-2.19

Netto-Cashflow:

$-82.44M

1W Leistung:

-14.55%

1M Leistung:

-90.98%

6M Leistung:

-88.24%

1J Leistung:

-91.53%

1-Tages-Spanne:

$2.23

$2.41

1-Wochen-Bereich:

$2.23

$2.83

52-Wochen-Spanne:

$2.23

$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Firmenname

Cassava Sciences Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

512-501-2444

Adresse

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

SAVA's Discussions on Twitter

Vergleichen Sie SAVA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SAVA Cassava Sciences Inc	2.35	113.06M	0	-97.22M	-82.44M	-2.32
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-26	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-10-08	Hochstufung	H.C. Wainwright	Neutral → Buy
2024-07-01	Herabstufung	H.C. Wainwright	Buy → Neutral
2022-11-16	Herabstufung	B. Riley Securities	Buy → Neutral
2021-07-15	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2021-07-07	Bestätigt	Maxim Group	Buy
2021-04-27	Eingeleitet	B. Riley Securities	Buy
2021-02-16	Bestätigt	H.C. Wainwright	Buy
2020-10-23	Eingeleitet	Cantor Fitzgerald	Overweight
2020-09-23	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-05-18	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-05-15	Herabstufung	Maxim Group	Buy → Hold
2020-01-10	Bestätigt	Maxim Group	Buy

Alle ansehen

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

Dec 20, 2024

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - The Malaysian Reserve

Dec 20, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

Dec 20, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Dec 20, 2024

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava - GlobeNewswire

Dec 20, 2024

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact The Gross Law Firm - Longview News-Journal

Dec 20, 2024

Dec 19, 2024

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors - GlobeNewswire

Dec 19, 2024

SAVA Stock Plummets to 52-Week Low at $2.33 Amid Market Challenges - Investing.com

Dec 19, 2024

Dec 18, 2024

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Dec 18, 2024

SAVA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 18, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Dec 18, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PR Newswire

Dec 18, 2024

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT: - GlobeNewswire

Dec 18, 2024

Dec 17, 2024

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - GlobeNewswire Inc.

Dec 17, 2024

CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

Dec 17, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava - GlobeNewswire

Dec 17, 2024

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 17, 2024

Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAVA - Longview News-Journal

Dec 17, 2024

Dec 16, 2024

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Cassava Sciences, Inc. - PR Newswire

Dec 16, 2024

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. - EIN News

Dec 16, 2024

Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire

Dec 16, 2024

The Manufacturers Life Insurance Company Sells 7,458 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Dec 16, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 16, 2024

Dec 15, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 15, 2024

Dec 14, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava - GlobeNewswire

Dec 14, 2024

Dec 13, 2024

SAVA Investors with Losses in Excess of $100K Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Dec 13, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Dec 13, 2024

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Bakersfield Californian

Dec 13, 2024

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Dec 13, 2024

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 13, 2024

375,000 Shares in Cassava Sciences, Inc. (NASDAQ:SAVA) Bought by Tidal Investments LLC - MarketBeat

Dec 13, 2024

Dec 12, 2024

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire

Dec 12, 2024

Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP - TipRanks

Dec 12, 2024

Cassava Shares Sink as CEO Resigns From Troubled Biotech Company - MSN

Dec 12, 2024

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges - Investing.com India

Dec 11, 2024

RIP simufilam, we hardly knew ye - Healthcare Brew

Dec 11, 2024

Dec 09, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect - AccessWire

Dec 09, 2024

Dec 08, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out - AccessWire

Dec 08, 2024

Dec 06, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Dec 06, 2024

Dec 05, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Investors to Learn More About the Investigation - AccessWire

Dec 05, 2024

Dec 04, 2024